{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:10:20Z","timestamp":1793394620960,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100021777","name":"American Society for Nutrition","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021777","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006639","name":"Grant Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006639","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1053\/j.ajkd.2026.05.002","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T08:29:13Z","timestamp":1784622553000},"page":"179-195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Management of Lupus Nephritis"],"prefix":"10.1053","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9912-4959","authenticated-orcid":false,"given":"Sayna","family":"Norouzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0189-4691","authenticated-orcid":false,"given":"Gabriel N.","family":"Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1 suppl","key":"10.1053\/j.ajkd.2026.05.002_bib1","first-page":"S1","article-title":"KDIGO 2024 clinical practice guideline for the management of lupus nephritis","volume":"105","year":"2024","journal-title":"Kidney Int"},{"issue":"14","key":"10.1053\/j.ajkd.2026.05.002_bib2","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1177\/0961203309345753","article-title":"Sensitivity and specificity of autoantibody tests in the differential diagnosis of lupus nephritis","volume":"18","author":"Heidenreich","year":"2009","journal-title":"Lupus"},{"issue":"9","key":"10.1053\/j.ajkd.2026.05.002_bib3","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/art.43212","article-title":"2024 American College of Rheumatology (ACR) guideline for the screening, treatment, and management of lupus nephritis","volume":"77","author":"Sammaritano","year":"2025","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1053\/j.ajkd.2026.05.002_bib4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7326\/M14-1030","article-title":"Multitarget therapy for induction treatment of lupus nephritis: a randomized trial","volume":"162","author":"Liu","year":"2015","journal-title":"Ann Intern Med"},{"issue":"10289","key":"10.1053\/j.ajkd.2026.05.002_bib5","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/S0140-6736(21)00578-X","article-title":"Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial","volume":"397","author":"Rovin","year":"2021","journal-title":"Lancet"},{"issue":"12","key":"10.1053\/j.ajkd.2026.05.002_bib6","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJMoa2001180","article-title":"Two-year, randomized, controlled trial of belimumab in lupus nephritis","volume":"383","author":"Furie","year":"2020","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1053\/j.ajkd.2026.05.002_bib7","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJMoa2410965","article-title":"Efficacy and safety of obinutuzumab in active lupus nephritis","volume":"392","author":"Furie","year":"2025","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1053\/j.ajkd.2026.05.002_bib8","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.kint.2024.09.007","article-title":"Urinary biomarkers for active lupus nephritis that have survived independent validation across cohorts","volume":"106","author":"Vodehnal","year":"2024","journal-title":"Kidney Int"},{"issue":"20","key":"10.1053\/j.ajkd.2026.05.002_bib9","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1056\/NEJMoa1014460","article-title":"Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis","volume":"365","author":"Dooley","year":"2011","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1053\/j.ajkd.2026.05.002_bib10","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1136\/ard.2010.131995","article-title":"Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial","volume":"69","author":"Houssiau","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"24","key":"10.1053\/j.ajkd.2026.05.002_bib11","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1056\/NEJMoa020009","article-title":"The natural history of chronic allograft nephropathy","volume":"349","author":"Nankivell","year":"2003","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1053\/j.ajkd.2026.05.002_bib12","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM198409133111103","article-title":"Cyclosporine-associated chronic nephropathy","volume":"311","author":"Myers","year":"1984","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1053\/j.ajkd.2026.05.002_bib13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/1573397115666190626111847","article-title":"The prevalence and causes of non-adherence to immunosuppressive medications in patients with lupus nephritis flares","volume":"16","author":"Ali","year":"2020","journal-title":"Curr Rheumatol Rev"},{"issue":"10","key":"10.1053\/j.ajkd.2026.05.002_bib14","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1136\/annrheumdis-2022-222435","article-title":"Weaning of maintenance immunosuppressive therapy in lupus nephritis (WIN-Lupus): results of a multicentre randomised controlled trial","volume":"81","author":"Jourde-Chiche","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1053\/j.ajkd.2026.05.002_bib15","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1177\/0961203313518625","article-title":"The value of repeat kidney biopsy in quiescent Argentinian lupus nephritis patients","volume":"23","author":"Alvarado","year":"2014","journal-title":"Lupus"},{"issue":"4","key":"10.1053\/j.ajkd.2026.05.002_bib16","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.kint.2018.05.021","article-title":"A prospective observational cohort study highlights kidney biopsy findings of lupus nephritis patients in remission who flare following withdrawal of maintenance therapy","volume":"94","author":"De Rosa","year":"2018","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2026.05.002_bib17","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.kint.2019.07.018","article-title":"Kidney biopsy-based management of maintenance immunosuppression is safe and may ameliorate flare rate in lupus nephritis","volume":"97","author":"Malvar","year":"2020","journal-title":"Kidney Int"},{"issue":"10437","key":"10.1053\/j.ajkd.2026.05.002_bib18","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(24)00424-0","article-title":"CAR T-cell therapy rescues adolescent with rapidly progressive lupus nephritis from haemodialysis","volume":"403","author":"Krickau","year":"2024","journal-title":"Lancet"},{"issue":"10","key":"10.1053\/j.ajkd.2026.05.002_bib19","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/s41591-022-02017-5","article-title":"Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus","volume":"28","author":"Mackensen","year":"2022","journal-title":"Nat Med"},{"issue":"1","key":"10.1053\/j.ajkd.2026.05.002_bib20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12016-025-09114-6","article-title":"Chimeric antigen receptor T cell therapy in systemic lupus erythematosus: mechanisms, clinical advances, and future directions a comprehensive review","volume":"68","author":"Matarneh","year":"2025","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"10.1053\/j.ajkd.2026.05.002_bib21","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/S2352-3026(17)30026-1","article-title":"Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study","volume":"4","author":"Bendapudi","year":"2017","journal-title":"Lancet Haematol"},{"issue":"3","key":"10.1053\/j.ajkd.2026.05.002_bib22","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/bjh.15932","article-title":"Utilizing a PLASMIC score-based approach in the management of suspected immune thrombotic thrombocytopenic purpura: a cost minimization analysis within the Harvard TMA Research Collaborative","volume":"186","author":"Upadhyay","year":"2019","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1053\/j.ajkd.2026.05.002_bib23","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/art.30293","article-title":"Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006","volume":"63","author":"Costenbader","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1053\/j.ajkd.2026.05.002_bib24","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1016\/j.transproceed.2011.08.092","article-title":"Preemptive kidney transplantation in systemic lupus erythematosus","volume":"43","author":"Naveed","year":"2011","journal-title":"Transplant Proc"},{"issue":"8","key":"10.1053\/j.ajkd.2026.05.002_bib25","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1177\/09612033251344189","article-title":"Trends of preemptive kidney transplantation in lupus compared to other primary diseases leading to end stage kidney disease in the United States of America","volume":"34","author":"Contreras","year":"2025","journal-title":"Lupus"},{"issue":"4","key":"10.1053\/j.ajkd.2026.05.002_bib26","doi-asserted-by":"crossref","first-page":"240","DOI":"10.7326\/M18-1570","article-title":"Renal transplantation and survival among patients with lupus nephritis: a cohort study","volume":"170","author":"Jorge","year":"2019","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1053\/j.ajkd.2026.05.002_bib27","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/acr.22482","article-title":"Association of time to kidney transplantation with graft failure among U.S. patients with end-stage renal disease due to lupus nephritis","volume":"67","author":"Plantinga","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"11","key":"10.1053\/j.ajkd.2026.05.002_bib28","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.2215\/CJN.02500314","article-title":"Comparison of mortality of ESRD patients with lupus by initial dialysis modality","volume":"9","author":"Contreras","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2026.05.002_bib29","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.transproceed.2013.11.085","article-title":"Influence of pretransplantation dialysis time and lupus activity on outcome of kidney transplantation in systemic lupus erythematosus","volume":"46","author":"Chung","year":"2014","journal-title":"Transplant Proc"},{"issue":"6","key":"10.1053\/j.ajkd.2026.05.002_bib30","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.semarthrit.2016.09.008","article-title":"The utility of lupus serology in predicting outcomes of renal transplantation in lupus patients: systematic literature review and analysis of the Toronto lupus cohort","volume":"46","author":"Yap","year":"2017","journal-title":"Semin Arthritis Rheum"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638626009212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638626009212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T22:28:21Z","timestamp":1785968901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638626009212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0272638626009212"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2026.05.002","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Management of Lupus Nephritis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2026.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}